Implementing Pharmacogenomics in the Discovery Pipeline

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.3, 2005-03, pp. : 3-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenomics and the Drug Discovery Pipeline: When Should it Be Implemented?

By Penny Michelle A. McHale Duncan

American Journal of PharmacoGenomics, Vol. 5, Iss. 1, 2005-01 ,pp. : 53-62

Adis International

Access to resources Recommend Favorite

Pharmacogenomics has promising applications in a number of areas of the drug discovery pipeline

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 11, 2005-11 ,pp. : 24-26

Adis International

Access to resources Recommend Favorite

Pharmacogenomics: Integration into Drug Discovery and Development

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-09 ,pp. : 1039-1046

Bentham Science Publishers

Access to resources Recommend Favorite

SNP Discovery and Typing Technologies for Pharmacogenomics

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 13, 2004-09 ,pp. : 1421-1429

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics and public health: implementing ‘populationalized’ medicine

By Mette Lindsey Mitropoulos Konstantinos Vozikis Athanassios Patrinos George P

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 803-813

Future Medicine

Access to resources Recommend Favorite